Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC133+ and MNC in Acute Myocardial Infarction during CABG
NCT01167751Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Jan 2008
- Primary completion
- Jun 2012
- Countries
- 1
01
Overview
A Phase 3 trial of autologous CD133+ bone marrow-derived stem cells in myocardial infarction (MI), sponsored by Royan Institute. Started Jan 2008; status: completed.
02
Drugs
autologous CD133+ bone marrow-derived stem cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01167751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167751.